SpectraCure AB (publ) OMXSTO:SPEC:
Q-PRO® PATENT APPROVED IN JAPAN
Spectracure Q-Pro Patent Approved In Japan
Earlier from Spectracure Ab
- Spectracure Gets Approval To Commence Clinical Trial
- Spectracure Appoints Johannes Swartling As CEO
- Spectracure Reports Positive Results In Prostate Cancer Study